Carbapenem-resistant Citrobacter spp. isolated in Spain from 2013 to 2015 produced a variety of carbapenemases including VIM-1, OXA-48, KPC-2, NDM-1 and VIM-2
- PMID: 29029114
- DOI: 10.1093/jac/dkx325
Carbapenem-resistant Citrobacter spp. isolated in Spain from 2013 to 2015 produced a variety of carbapenemases including VIM-1, OXA-48, KPC-2, NDM-1 and VIM-2
Abstract
Objectives: There is little information about carbapenemase-producing (CP) Citrobacter spp. We studied the molecular epidemiology and microbiological features of CP Citrobacter spp. isolates collected in Spain (2013-15).
Methods: In total, 119 isolates suspected of being CP by the EUCAST screening cut-off values were analysed. Carbapenemases and ESBLs were characterized using PCR and sequencing. The genetic relationship among Citrobacter freundii isolates was studied by PFGE.
Results: Of the 119 isolates, 63 (52.9%) produced carbapenemases, of which 37 (58.7%) produced VIM-1, 20 (31.7%) produced OXA-48, 12 (19%) produced KPC-2, 2 (3.2%) produced NDM-1 and 1 (1.6%) produced VIM-2; 9 C. freundii isolates co-produced VIM-1 plus OXA-48. Fourteen isolates (22.2%) also carried ESBLs: 8 CTX-M-9 plus SHV-12, 2 CTX-M-9, 2 SHV-12 and 2 CTX-M-15. Fifty-seven isolates (90.5%) were C. freundii, 4 (6.3%) were Citrobacter koseri, 1 (1.6%) was Citrobacter amalonaticus and 1 (1.6%) was Citrobacter braakii. By EUCAST breakpoints, eight (12.7%) of the CP isolates were susceptible to the four carbapenems tested. In the 53 CP C. freundii analysed by PFGE, a total of 44 different band patterns were observed. Four PFGE clusters were identified: cluster 1 included eight isolates co-producing VIM-1 and OXA-48; blaVIM-1 was carried in a class 1 integron (intI-blaVIM-1-aacA4-dfrB1-aadA1-catB2-qacEΔ1/sul1) and blaOXA-48 was carried in a Tn1999.2 transposon.
Conclusions: We observed the clonal and polyclonal spread of CP Citrobacter spp. across several Spanish geographical areas. Four species of Citrobacter spp. produced up to five carbapenemase types, including co-production of VIM-1 plus OXA-48. Some CP Citrobacter spp. isolates were susceptible to the four carbapenems tested, a finding with potential clinical implications.
© The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Similar articles
-
Characterization of mobile genetic elements carrying VIM-1 and KPC-2 carbapenemases in Citrobacter freundii isolates in Madrid.Int J Med Microbiol. 2017 Sep;307(6):340-345. doi: 10.1016/j.ijmm.2017.07.001. Epub 2017 Jul 8. Int J Med Microbiol. 2017. PMID: 28711315
-
Characterization of carbapenemase-producing Enterobacteriaceae from colonized patients in a university hospital in Madrid, Spain, during the R-GNOSIS project depicts increased clonal diversity over time with maintenance of high-risk clones.J Antimicrob Chemother. 2018 Nov 1;73(11):3039-3043. doi: 10.1093/jac/dky284. J Antimicrob Chemother. 2018. PMID: 30053018 Clinical Trial.
-
A single-day point-prevalence study of faecal carriers in long-term care hospitals in Madrid (Spain) depicts a complex clonal and polyclonal dissemination of carbapenemase-producing Enterobacteriaceae.J Antimicrob Chemother. 2016 Feb;71(2):348-52. doi: 10.1093/jac/dkv355. Epub 2015 Oct 30. J Antimicrob Chemother. 2016. PMID: 26518051
-
OXA-48-like carbapenemases producing Enterobacteriaceae in different niches.Eur J Clin Microbiol Infect Dis. 2018 Apr;37(4):587-604. doi: 10.1007/s10096-017-3112-7. Epub 2017 Oct 8. Eur J Clin Microbiol Infect Dis. 2018. PMID: 28990132 Review.
-
Epidemiology of Citrobacter spp. infections among hospitalized patients: a systematic review and meta-analysis.BMC Infect Dis. 2024 Jul 2;24(1):662. doi: 10.1186/s12879-024-09575-8. BMC Infect Dis. 2024. PMID: 38956542 Free PMC article.
Cited by
-
Epidemiology of β-Lactamase-Producing Pathogens.Clin Microbiol Rev. 2020 Feb 26;33(2):e00047-19. doi: 10.1128/CMR.00047-19. Print 2020 Mar 18. Clin Microbiol Rev. 2020. PMID: 32102899 Free PMC article. Review.
-
Characterization of an NDM-1-Producing Citrobacter koseri Isolate from China.Infect Drug Resist. 2024 Jan 6;17:61-67. doi: 10.2147/IDR.S435771. eCollection 2024. Infect Drug Resist. 2024. PMID: 38205064 Free PMC article.
-
Antimicrobial Resistance and Molecular Characterization of Citrobacter spp. Causing Extraintestinal Infections.Front Cell Infect Microbiol. 2021 Aug 27;11:737636. doi: 10.3389/fcimb.2021.737636. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34513738 Free PMC article.
-
Clinical and Genomic Epidemiology of Carbapenem-Nonsusceptible Citrobacter spp. at a Tertiary Health Care Center over 2 Decades.J Clin Microbiol. 2020 Aug 24;58(9):e00275-20. doi: 10.1128/JCM.00275-20. Print 2020 Aug 24. J Clin Microbiol. 2020. PMID: 32554477 Free PMC article.
-
High frequency of carbapenem-resistant Enterobacteriaceae fecal carriage among ICU hospitalized patients from Southern Iran.Iran J Basic Med Sci. 2022 Dec;25(12):1416-1423. doi: 10.22038/IJBMS.2022.63099.13938. Iran J Basic Med Sci. 2022. PMID: 36544530 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous